Novavax Announces Positive Results from First Study of Influenza Vaccine and COVID-19 Vaccine Candidate Administered Simultaneously

COVID-19 vaccine candidate efficacy in those 18 to<65 years old was preserved in influenza vaccine recipients Influenza vaccine immunogenicity preserved Study demonstrated no early safety concerns Data available ahead of publication via...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials